Genetic variants on chromosome 9p21 confer a robust risk for coronary artery disease but inconsistent risk for stroke. This study investigated whether such genetic variants exert differential risks on myocardial infarction (MI) and ischemic stroke in a Taiwanese population.
Methods
The study recruited 425 MI patients, 687 patients with ischemic stroke, and 1377 healthy controls. Four key single nucleotide polymorphisms (SNPs) on chromosome 9p21 were genotyped.
Results
Multivariate permutation analyses demonstrated that the risk T allele of rs1333040 and G allele of rs2383207 were associated with MI (P = 0.045 and 0.002, respectively). Subjects with the rs2383207 GG genotype had a 1.85-fold (P = 0.021) risk for MI when compared with the subjects with the AA genotype. Further analysis showed that significant results only exist in the young MI group (<65 years) but not in the old MI group (≥65 years). These SNPs were not statistically significant for stroke (adjusted P ranged from 0.097 to 0.540). Haplotype analysis showed global P values of 0.032 for MI and 0.290 for stroke.
Conclusions
Genetic variations in the 9p21 region are associated with MI but not with stroke in a Taiwanese population. Early-onset MI was more likely to carry the risk genotypes of 9p21 SNPs.
HarmsenP, LappasG, RosengrenA, . Long-term risk factors for stroke: twenty-eight years of follow-up of 7457 middle-aged men in Goteborg, Sweden. Stroke. 2006;37:1663–1667.
2.
YusufS, HawkenS, OunpuuS, . Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–952.
3.
BroeckelU, HengstenbergC, MayerB, . A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet. 2002;30:210–214.
4.
HelgadottirA, ManolescuA, ThorleifssonG, . The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet. 2004;36:233–239.
5.
McPhersonR, PertsemlidisA, KavaslarN, . A common allele on chromosome 9 associated with coronary heart disease. Science. 2007;316:1488–1491.
6.
HelgadottirA, ThorleifssonG, ManolescuA, . A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 2007;316:1491–1493.
7.
SamaniNJ, ErdmannJ, HallAS, . Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357:443–453.
8.
ShenGQ, RaoS, MartinelliN, . Association between four SNPs on chromosome 9p21 and myocardial infarction is replicated in an Italian population. J Hum Genet. 2008;53:144–150.
9.
SchunkertH, GotzA, BraundP, . Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation. 2008;117:1675–1684.
10.
SaleheenD, AlexanderM, RasheedA, . Association of the 9p21.3 locus with risk of first-ever myocardial infarction in Pakistanis: case-control study in South Asia and updated meta-analysis of Europeans. Arterioscler Thromb Vasc Biol. 2010;30:1467–1473.
11.
ZhangQ, WangXF, ChengSS, . Three SNPs on chromosome 9p21 confer increased risk of myocardial infarction in Chinese subjects. Atherosclerosis. 2009;207:26–28.
12.
ShenGQ, LiL, RaoS, . Four SNPs on chromosome 9p21 in a South Korean population implicate a genetic locus that confers high cross-race risk for development of coronary artery disease. Arterioscler Thromb Vasc Biol. 2008;28:360–365.
13.
HiuraY, FukushimaY, YunoM, . Validation of the association of genetic variants on chromosome 9p21 and 1q41 with myocardial infarction in a Japanese population. Circ J. 2008;72:1213–1217.
14.
PasmantE, LaurendeauI, HeronD, . Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res. 2007;67:3963–3969.
15.
HoldtLM, BeutnerF, ScholzM, . ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arterioscler Thromb Vasc Biol. 2010;30:620–627.
16.
YeS, WilleitJ, KronenbergF, . Association of genetic variation on chromosome 9p21 with susceptibility and progression of atherosclerosis: a population-based, prospective study. J Am Coll Cardiol. 2008;52:378–384.
17.
BjorckHM, LanneT, AlehagenU, . Association of genetic variation on chromosome 9p21.3 and arterial stiffness. J Intern Med. 2009;265:373–381.
18.
HelgadottirA, ThorleifssonG, MagnussonKP, . The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet. 2008;40:217–224.
19.
MatarinM, BrownWM, SingletonA, . Whole genome analyses suggest ischemic stroke and heart disease share an association with polymorphisms on chromosome 9p21. Stroke. 2008;39:1586–1589.
20.
WahlstrandB, Orho-MelanderM, DellingL, . The myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of coronary events in patients with hypertension. J Hypertens. 2009;27:769–773.
21.
LemmensR, AbboudS, RobberechtW, . Variant on 9p21 strongly associates with coronary heart disease, but lacks association with common stroke. Eur J Hum Genet. 2009;17:1287–1293.
22.
ZeeRY, RidkerPM. Two common gene variants on chromosome 9 and risk of atherothrombosis. Stroke. 2007;38:e111.
23.
EllisKL, PilbrowAP, FramptonCM, . A common variant at chromosome 9P21.3 is associated with age of onset of coronary disease but not subsequent mortality. Circ Cardiovasc Genet. 2010;3:286–293.
24.
Investigators WMPP The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol. 1988;41:105–114.
25.
AdamsHPJr, BendixenBH, KappelleLJ, . Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35–41.
26.
BarrettJC, FryB, MallerJ, . Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–265.
27.
TzengJY, WangCH, KaoJT, . Regression-based association analysis with clustered haplotypes through use of genotypes. Am J Hum Genet. 2006;78:231–242.
28.
PurcellS, NealeB, Todd-BrownK, . PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–575.
29.
GschwendtnerA, BevanS, ColeJW, . Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. Ann Neurol. 2009;65:531–539.
30.
OlssonS, JoodK, BlomstrandC, . Genetic variation on chromosome 9p21 shows association with the ischaemic stroke subtype large-vessel disease in a Swedish sample aged ≤70. Eur J Neurol. 2011;18(2):365–367.
31.
ZhouL, ZhangX, HeM, . Associations between single nucleotide polymorphisms on chromosome 9p21 and risk of coronary heart disease in Chinese Han population. Arterioscler Thromb Vasc Biol. 2008;28:2085–2089.
32.
PengWH, LuL, ZhangQ, . Chromosome 9p21 polymorphism is associated with myocardial infarction but not with clinical outcome in Han Chinese. Clin Chem Lab Med. 2009;47:917–922.
33.
ChenZ, QianQ, MaG, . A common variant on chromosome 9p21 affects the risk of early-onset coronary artery disease. Mol Biol Rep. 2009;36:889–893.
34.
LinHF, TsaiPC, LinRT, . Sex differential genetic effect of chromosome 9p21 on subclinical atherosclerosis. PLoS One. 2010;5(11):e15124.
35.
ZdravkovicS, WienkeA, PedersenNL, . Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins. J Intern Med. 2002;252:247–254.
36.
DingH, XuY, WangX, . 9p21 is a shared susceptibility locus strongly for coronary artery disease and weakly for ischemic stroke in Chinese Han population. Circ Cardiovasc Genet. 2009;2:338–346.
37.
EverettBM, KurthT, BuringJE, . The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women. J Am Coll Cardiol. 2006;48:2235–2242.
38.
OzakiK, SatoH, InoueK, . SNPs in BRAP associated with risk of myocardial infarction in Asian populations. Nat Genet. 2009;41:329–333.
